Subrata Roy
Subrata Roy
Verified email at
Cited by
Cited by
Computational modelling supports that dengue virus envelope antibodies can bind to SARS-CoV-2 receptor binding sites: Is pre-exposure to dengue virus protective against COVID …
H Nath, A Mallick, S Roy, S Sukla, S Biswas
Computational and Structural Biotechnology Journal 19, 459-466, 2021
Archived dengue serum samples produced false-positive results in SARS-CoV-2 lateral flow-based rapid antibody tests
H Nath, A Mallick, S Roy, S Sukla, K Basu, A De, S Biswas
Journal of Medical Microbiology 70 (6), 001369, 2021
COVID-19 serum can be cross-reactive and neutralizing against the dengue virus, as observed by the dengue virus neutralization test
H Nath, A Mallick, S Roy, T Kayal, S Ranjan, S Sengupta, S Sukla, ...
International Journal of Infectious Diseases 122, 576-584, 2022
Non-cytopathic herpes simplex virus type-1 isolated from acyclovir-treated patients with recurrent infections
S Roy, S Sukla, A De, S Biswas
Scientific reports 12 (1), 1345, 2022
Hepatitis B virus detected in paper currencies in a densely populated city of India: A plausible source of horizontal transmission?
P Das, R Supekar, R Chatterjee, S Roy, A Ghosh, S Biswas
World Journal of Hepatology 12 (10), 775, 2020
Occult hepatitis B virus infections (often with human herpesvirus 7 co-infection) detected in Pityriasis rosea patients: A pilot study
A De, S Roy, S Sukla, A Ansari, S Biswas
Indian Journal of Dermatology 62 (6), 598-605, 2017
Regarding: Masyeni S, Santoso MS, Widyaningsih PD, Wedha Asmara DG, Nainu F, Harapan H, et al. Serological cross-reaction and co-infection of dengue and COVID-19 in Asia …
S Biswas, S Sukla, S Roy, H Nath, A Mallick
International Journal of Infectious Diseases 104, 737, 2021
SARS-CoV-2 has observably higher propensity to accept uracil as nucleotide substitution: Prevalence of amino acid substitutions and their predicted functional implications in …
S Roy, H Nath, A Mallick, S Biswas
bioRxiv, 2020.10. 07.329771, 2020
The system can't perform the operation now. Try again later.
Articles 1–8